Bioretec Oy (HEL:BRETEC)
0.0246
+0.0072 (41.38%)
At close: May 18, 2026
Bioretec Oy Earnings Call Transcripts
Fiscal Year 2025
-
2025 was a transformative year with leadership changes, strategic resets, and strong regulatory wins. U.S. direct sales grew over 60% quarter-over-quarter, but total revenue dipped due to distribution model changes and one-off items. Focus remains on commercial growth and capital strengthening.